See all the latest news, blogs and updates from the medical sector.
COVID-19 vaccination for children and young people aged 12-17 years
It is recognised that a small number of children and young people aged 12-17 years with specific underlying health conditions may be at...
NICE unfortunately leans towards a no for the treatment of Metachromatic Leukodystrophy (MLD).
The drug decision-making body NICE (National Institute of Clinical Excellence) has publicly released its interim decision today (9 July...
Willow Foundation Special Days and Treats
For people living with a life-threatening illness, every day is precious. The pressures of diagnosis, treatment and recovery can have a...

APPG on Newborn screening
On 9 June 2021, we attended a virtual APPG (All Party Parliamentary Group) meeting on Rare, Genetic and Undiagnosed Conditions about...
Vimizim update from NICE for MPS IVA (Morquio)
Update 10 June 2021: Dear stakeholders, BioMarin has requested an extension to the timelines for the re-evaluation for elosulfase alfa...
At home self-infusions - Carers Week 2021
In early June, the #CarersWeek campaign is celebrated annually online to bring awareness to challenges unpaid carers face and to...
New COHERE study for MPS II patients
A study is currently being undertaken by the COHERE team at the Royal Manchester Children’s Hospital. ‘COHERE’ is an abbreviation of Core...
Phase I/II clinical study to explore the potential of ST-920 investigational gene therapy to treat
Below is a patient newsletter from biotechnology company Sangamo about their Fabry gene therapy trial. The STAAR Study is Recruiting...
MPS Society's chance to win £1,000
MPS Society are asking for nominations to win a £1,000 Movement for Good award from Ecclesiastical Insurance Group. MPS Society is...
Lexie's story
Lexie's sister Tillie Mae has MPS IIIA. Here, she shares her story about what it's like growing up with a sister who has a rare disease....